In 2017, the Food and Drug Administration approved Ozempic to treat Type 2 diabetes, but people have also used the drug off-label to lose weight
Possible oral-health risks with GLP-1 use include reduced saliva from eating less, vomiting or acid reflux that exposes teeth to stomach acid, and nutritional gaps that can affect gums
FDA Press Release on First Treatment for Menkes Disease Rare Disease: FDA Expands Treatment Approval for Gaucher Disease The FDA expanded the approval of Sanofis Cerezyme (imiglucerase) intravenous infusion enzyme replacement therapy to treat non-neurological symptoms in patients with Type 3 Gaucher disease, which is the rarest and most serious type
The first day of GLP-1 treatment typically begins with a subcutaneous injection, usually administered in the abdomen, thigh, or upper arm
Practical protocols: how to combine HRT and GLP-1 safely Theory is useful
The cellular processes behind nad with glutathione therapy show powerful anti-aging and detoxification mechanisms